pharmachologic effect
Gefal-Belmed has an acid-neutralizing, adsorbing and enveloping effect. Quickly reduces intracavitary acidity of gastric juice to physiological pH values. Maintains a normal level of acidity in the stomach for a long time without disturbing digestive conditions. Promotes binding and removal of toxic substances from the stomach. It forms a protective film on the mucous membrane of the gastrointestinal tract, which promotes the restoration of mucosal cells and the healing of ulcers.
Indications:
Acute gastritis; chronic gastritis with increased and normal secretory function of the stomach (in the acute phase); acute duodenitis; peptic ulcer of the stomach and duodenum (in the acute phase); symptomatic ulcers of various origins; erosion of the gastrointestinal mucosa; reflux esophagitis (including in children); hiatal hernia; non-ulcer dyspepsia syndrome, functional diseases of the large intestine, colopathies, enterocolitis, sigmoiditis, proctitis, diverticulitis, diarrhea in patients after gastrectomy; poisoning; acute pancreatitis, chronic pancreatitis (in the acute phase); gastralgia, heartburn (after excessive consumption of ethanol, nicotine, coffee, taking drugs, errors in diet); gastrointestinal disorders when taking drugs and cauterizing substances (acid, alkali), dyspepsia of neurotic origin. Prophylactically to reduce the absorption of radioactive elements.
Instructions for use and dosage
- 1 tablespoon contains 14 g of medicine, which corresponds to 1.26 g of aluminum phosphate.
- Shake the contents of the bottle for 1-2 minutes before use. Adults and children over 12 years of age, take 1-3 tablespoons orally 2-3 times a day (i.e. 1.26-3.78 g 2-3 times a day or from 2.52 g to 11.34 g aluminum phosphate) 30-40 minutes after meals or in the evening before bed, or if pain or heartburn occurs.
- If you miss another dose, you should take it as quickly as possible. If the time for your next dose has come, you do not need to take a double dose to replenish the forgotten one, just continue taking Gefal Belmed according to the recommended regimen.
Storage
This product must be placed in a room where the temperature will not exceed 25 degrees. In addition, under no circumstances should droplets of water or sunlight fall into the selected location.
Attention! It is necessary to carefully ensure that children do not handle the medicine, because Uncontrolled use of the drug can significantly harm the child’s body!
The shelf life of this medicine is two years. After opening, the suspension can be stored at 5 degrees for one month.
Video on the topic: Phosphalugel promotional video
Side effect
When taken in large doses and with long-term use, the drug may cause constipation. In this case, it is recommended to take enough fluid.
Very rarely (<1/10000) allergic reactions, burning in the mouth, nausea, flatulence, and dizziness may occur. With prolonged use in high doses, very rarely (<1/10,000) extrapyramidal motor disorders and memory loss may occur.
If side effects or reactions not listed in these instructions occur, you should consult a doctor.
Reviews
This drug has many positive reviews. People really like the convenient form of release, as well as the method of administration. In addition, pregnant girls really like the possibility of taking the product during pregnancy.
Among the disadvantages, patients note the presence of a large list of side effects. In addition, some patients are not satisfied with the high cost of the medicine. There are reports from patients that the drug did not have any therapeutic effect.
Precautionary measures
You should not take the medicine for a long time without a doctor's prescription. If symptoms do not disappear after taking the drug within 7 days, you should consult your doctor.
- Use with caution in the presence of kidney disease, liver cirrhosis, severe heart failure. In elderly patients and patients with impaired renal function, when using Hefala-Belmed in recommended doses, an increase in the concentration of aluminum in the blood serum is possible. The drug is not used in the treatment of decompensated renal failure, since aluminum phosphate does not cause hypophosphatemia.
- Animal studies have shown reproductive toxicity of aluminum compounds.
- Human studies have shown that aluminum accumulates in the bone tissue of premature newborns. There is a potential risk of neurotoxicity with long-term use.
- When used simultaneously with drugs that have a dosage form coated with an enteric coating, it should be taken into account that an increase in gastric pH leads to more rapid destruction of the enteric coating.
- The drug contains sugar, which should be taken into account by patients with diabetes. 1 tablespoon contains less than 1/10 XE.
- Patients with rare congenital fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency should not take this medicine.
- Hefal-Belmed contains parabens, which can cause allergic reactions (possibly delayed).
- The use of the drug Hefal-Belmed does not affect the results of x-ray examination.
- In elderly patients, an increase in the concentration of aluminum in the blood serum is possible.
Gefal-Belmed suspension 230g
Name
Hefal-BELMED.
Description
A suspension of white or white with a yellowish or brown tint, sweetish taste, with the smell of “Raspberry” flavoring. After shaking it should be homogeneous.
Main active ingredient
Aluminum phosphate.
Release form
Suspension.
pharmachologic effect
Gefal-Belmed has an acid-neutralizing, adsorbing and enveloping effect. Quickly reduces intracavitary acidity of gastric juice to physiological pH values. Maintains a normal level of acidity in the stomach for a long time without disturbing digestive conditions. Promotes binding and removal of toxic substances from the stomach. It forms a protective film on the mucous membrane of the gastrointestinal tract, which promotes the restoration of mucosal cells and the healing of ulcers.
Indications for use
Symptomatic treatment of pain and heartburn in diseases of the upper gastrointestinal tract and duodenum.
Directions for use and doses
1 tablespoon contains 14 g of medicine, which corresponds to 1.26 g of aluminum phosphate. Shake the contents of the bottle for 1-2 minutes before use. Adults and children over 12 years of age, take 1-3 tablespoons orally 2-3 times a day (i.e. 1.26-3.78 g 2-3 times a day or from 2.52 g to 11.34 g aluminum phosphate) 30-40 minutes after meals or in the evening before bed, or if pain or heartburn occurs. If you miss another dose, you should take it as quickly as possible. If the time for your next dose has come, you do not need to take a double dose to replenish the forgotten one, just continue further taking Gefalb-Belmed according to the recommended regimen.
Use during pregnancy and lactation
Use during pregnancy and lactation should be done with extreme caution and only as prescribed by a doctor. If necessary, this drug is used during pregnancy only in a low dose to avoid the accumulation of aluminum in the child’s bone tissue.
Precautionary measures
You should not take the medicine for a long time without a doctor's prescription. If symptoms do not disappear after taking the drug within 7 days, you should consult your doctor. Use with caution in the presence of kidney disease, liver cirrhosis, severe heart failure. In elderly patients and patients with impaired renal function, when using Hefala-Belmed in recommended doses, an increase in the concentration of aluminum in the blood serum is possible. The drug is not used in the treatment of decompensated renal failure, since aluminum phosphate does not cause hypophosphatemia. Animal studies have shown reproductive toxicity of aluminum compounds. Human studies have shown that aluminum accumulates in the bone tissue of premature newborns. There is a potential risk of neurotoxicity with long-term use. When used simultaneously with drugs that have a dosage form coated with an enteric coating, it should be taken into account that an increase in gastric pH leads to more rapid destruction of the enteric coating. The drug contains sugar, which should be taken into account by patients with diabetes. 1 tablespoon contains less than 1/10 XE. Patients with rare congenital fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency should not take this medicine. Hefal-Belmed contains parabens, which can cause allergic reactions (possibly delayed). The use of the drug Hefal-Belmed does not affect the results of x-ray examination. In elderly patients, an increase in the concentration of aluminum in the blood serum is possible. Use during pregnancy and lactation. Impact on the ability to drive vehicles and other potentially dangerous mechanisms. The drug does not affect the ability to drive vehicles and potentially dangerous machinery.
Interaction with other drugs
Reduces the absorption of furosemide, tetracyclines, digoxin, isoniazid, indomethacin, ranitidine (should be taken no earlier than 2 hours after taking Hefala-Belmed). The simultaneous use of the drug with ciprofloxacin and ofloxacin leads to a decrease in the absorption of these antibacterial agents. When taking medications containing iron or sodium fluoride simultaneously with Hefal-Belmed, their absorption may also be reduced. Therefore, it is recommended to separate the intake of Hefala-Belmed and other medications by a two-hour time interval. Gefal-Belmed should not be taken simultaneously with acidic drinks (for example, fruit juices, wine, etc.), otherwise the undesirable absorption of aluminum phosphate may be increased.
Contraindications
Chronic renal failure; hypersensitivity or intolerance to drugs containing aluminum salts; fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency, severe constipation; children up to 12 years of age. With caution: kidney disease, liver cirrhosis, severe heart failure, edema, recent gastrointestinal bleeding.
Compound
Composition per bottle: active substance: aluminum phosphate gel - 20.7 g; excipients: white sugar, agar, methyl parahydroxybenzoate, propyl parahydroxybenzoate, Raspberry flavoring, purified water. Pharmacotherapeutic group: Drugs for the treatment of conditions associated with acidity disorders. Antacids.
Overdose
Symptoms: decreased intestinal motility. Treatment: prescription of laxatives. Long-term use in high doses, as well as use in renal failure, can lead to the accumulation of aluminum, especially in nerve and bone tissue. This can be expressed in memory impairment, disorientation, motor and mental disorders. Cessation of aluminum intake from all sources and treatment with deferoxamine is recommended.
Side effect
When taken in large doses and with long-term use, the drug may cause constipation. In this case, it is recommended to take enough fluid. Very rarely (
Storage conditions
In a place protected from moisture at a temperature not exceeding 25°C. After opening the bottle, store at a temperature not exceeding 5°C for no more than 1 month. Do not freeze. Keep out of the reach of children.
Buy Hefal-Belmed suspension 230g in a pharmacy
Price for Gefal-Belmed suspension 230g
Instructions for use for Gefal-Belmed suspension 230g
Interaction with other drugs
Reduces the absorption of furosemide, tetracyclines, digoxin, isoniazid, indomethacin, ranitidine (should be taken no earlier than 2 hours after taking Hefala-Belmed). The simultaneous use of the drug with ciprofloxacin and ofloxacin leads to a decrease in the absorption of these antibacterial agents. When taking medications containing iron or sodium fluoride simultaneously with Hefal Belmed, their absorption may also be reduced. Therefore, it is recommended to separate the intake of Hefala-Belmed and other medications by a two-hour time interval.
Hefal Belmed should not be taken simultaneously with acidic drinks (for example, fruit juices, wine, etc.), otherwise the undesirable absorption of aluminum phosphate may be increased.
